Registry for cardiovascular imaging in Canada

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Cardiovascular Imaging Registry of Canada (CIROC) is a multi-site, prospective observational study aimed at developing risk prediction models for patients with known or suspected cardiovascular diseases. It collects standardized imaging biomarkers, demographic data, and clinical outcomes from patients referred for non-invasive cardiac imaging. The registry focuses on cardiac MRI, CTA, and echocardiography, utilizing automated tools for patient engagement and data collection. Patients will be followed for up to 10 years, linking their data to administrative health records for comprehensive outcome assessment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients referred for hospital-based cardiac imaging services

Exclusion Criteria:

* Failure or provide informed consent

Where it's running

• Foothills Medical Centre
  Calgary, Alberta, Canada Recruiting
• South Health Campus
  Calgary, Alberta, Canada Recruiting
• Peter Lougheed Hospital
  Calgary, Alberta, Canada Recruiting
• Rockyview Hospital
  Calgary, Alberta, Canada Recruiting

Study contacts

• Principal investigator: James White — Director of Stephenson Cardiac Imaging Centre
• Study coordinator: James White
• Email: jawhit@ucalgary.ca
• Phone: 403-944-2805

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.